~0 spots leftby May 2025

Virtual Trauma Support for Autistic Adults with PTSD

Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Wyoming
No Placebo Group

Trial Summary

What is the purpose of this trial?

The goal of this single-group clinical trial is to learn about the initial efficacy and feasibility of telehealth-delivered Written Exposure Therapy (WET) for autistic adults with traumatic stress symptoms. The main questions the investigators aim to answer are: * Do symptoms of posttraumatic stress disorder (PTSD) and co-occurring mental health concerns decrease after receiving WET? * Do biobehavioral health outcomes, including objective (Fitbit indicators of activity, sleep, and heart rate) and subjectively-reported health variables (e.g., sleep, pain, health-related quality of life), improve after receiving WET? * How do autistic adults experience WET, and how can this program be modified and enhance in the future in collaboration with autistic adults? Participants will complete the following as part of the study, which is completed entirely over telehealth. * Participants will first complete an initial assessment, involving brief measures of cognition and autistic traits, as well as interviews and questionnaires about PTSD, mental health, and physical health. If eligible, participants will proceed to the following steps: * Eligible participants will then start wearing a Fitbit, to be used for the duration of the study. * Participants will then participate in 5 weekly virtual visits involving the WET protocol, including weekly brief assessment of PTSD and mental and physical health. * Then, participants will complete a sixth virtual visit the following week where PTSD, mental and physical health, and treatment feedback are assessed. * Lastly, participants will complete virtual visits 1 and 6 months later involving re-assessment of PTSD and mental and physical health. Therefore, this is a pre-post single group design, where all participants will receive WET to establish initial efficacy and feasibility. Investigators will also consult with an autistic advisory board throughout the project, and make adaptations as recommended in consultation with autistic adults. The goal is to better understand the initial efficacy and feasibility of WET for supporting autistic adults who have experienced trauma.

Do I have to stop taking my current medications to join the trial?

The trial protocol does not specify whether you need to stop taking your current medications. However, it does exclude participants who are currently receiving trauma-focused therapeutic services.

What data supports the idea that Virtual Trauma Support for Autistic Adults with PTSD is an effective treatment?

The available research shows that Written Exposure Therapy (WET) is effective for treating PTSD. One study found that WET, which involves only five sessions, led to significant improvements in PTSD symptoms, depressive symptoms, and overall functioning in patients. This suggests that WET can be a quick and efficient treatment option. Although the study was conducted in Korea, it highlights the potential benefits of WET for individuals with PTSD, including autistic adults. Compared to other treatments, WET requires less time and effort, making it a practical choice for many.12345

What safety data exists for Written Exposure Therapy (WET) for PTSD?

Written Exposure Therapy (WET) is a 5-session treatment for PTSD that has been shown to be non-inferior to Cognitive Processing Therapy (CPT) in terms of outcomes through 36 weeks, with gains maintained through 60 weeks. It is considered brief and tolerable, requiring limited patient and therapist time and no between-session assignments. Studies have demonstrated its efficacy in reducing PTSD symptoms, depressive symptoms, and improving global functioning levels, including among veterans and Korean patients with PTSD. These findings suggest that WET is a safe and effective treatment option for PTSD.45678

Is Written Exposure Therapy (WET) a promising treatment for autistic adults with PTSD?

Yes, Written Exposure Therapy (WET) is a promising treatment for PTSD. It is a short, 5-session therapy that has shown significant improvements in PTSD symptoms. It is efficient, requiring less time from both patients and therapists, and has been effective in various studies, including those involving veterans.23458

Research Team

Eligibility Criteria

This trial is for autistic adults over 18 who have experienced trauma and show significant traumatic stress symptoms. They must be comfortable with English, have basic internet access for telehealth visits, and score at least 65 on an intelligence test (WASI-2). Those not meeting these criteria or posing a safety risk are excluded.

Inclusion Criteria

I have experienced trauma and suffer from significant stress symptoms because of it.
Autistic
Comfortable speaking and writing in English
See 3 more

Exclusion Criteria

Participant does not have access to internet connected device for telehealth visits
Participant receives Full Scale Intelligence Quotient (FSIQ) score < 65 on the Wechsler Abbreviated Scale of Intelligence-Second Edition (WASI-2)
I cannot understand English.
See 3 more

Treatment Details

Interventions

  • Written Exposure Therapy (WET) (Behavioral Intervention)
Trial OverviewThe study tests the effectiveness of Written Exposure Therapy (WET) delivered via telehealth to reduce PTSD symptoms in autistic adults. It's a pre-post single group design where participants wear Fitbits and attend virtual sessions to assess changes in mental health, physical health, and biobehavioral indicators.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Written Exposure TherapyExperimental Treatment1 Intervention
Behavioral therapy: Written Exposure Therapy via telehealth

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Wyoming

Lead Sponsor

Trials
20
Recruited
1,600+

Findings from Research

In a study of 148 autistic youth aged 7-13 with anxiety disorders, the exposure phase of cognitive-behavioral therapy (CBT) led to significantly faster symptom reduction compared to the cognitive and psychoeducation phases, highlighting the effectiveness of exposure techniques in treating anxiety.
The findings suggest that cognitive strategies alone may slow down symptom improvement, indicating that therapists should prioritize moving quickly to exposure practices to enhance treatment efficacy for autistic youth.
Change during cognitive and exposure phases of cognitive-behavioral therapy for autistic youth with anxiety disorders.Guzick, AG., Schneider, SC., Kendall, PC., et al.[2023]
Children with autism spectrum disorder (ASD) who also have post-traumatic stress disorder (PTSD) are at a higher risk for suicidal thoughts and behaviors, highlighting the need for effective trauma treatments.
The paper presents adaptations for Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) specifically for children with ASD, including strategies for teletherapy that address both trauma and ASD behaviors, ensuring safety and flexibility in treatment.
TF-CBT Informed Teletherapy for Children with Autism and their Families.Romney, JS., Garcia, M.[2022]
In a study of 59 adults with autistic spectrum disorder (ASD), over 40% reported probable PTSD symptoms after experiencing both DSM-5 and non-DSM-5 traumatic events, indicating a heightened risk for PTSD in this population.
The findings suggest that a broader range of life events are perceived as traumatic by individuals with ASD, highlighting the need for mental health assessments to include non-DSM-5 traumas to ensure appropriate diagnosis and treatment for PTSD.
Experience of Trauma and PTSD Symptoms in Autistic Adults: Risk of PTSD Development Following DSM-5 and Non-DSM-5 Traumatic Life Events.Rumball, F., Happé, F., Grey, N.[2021]

References

Change during cognitive and exposure phases of cognitive-behavioral therapy for autistic youth with anxiety disorders. [2023]
TF-CBT Informed Teletherapy for Children with Autism and their Families. [2022]
Experience of Trauma and PTSD Symptoms in Autistic Adults: Risk of PTSD Development Following DSM-5 and Non-DSM-5 Traumatic Life Events. [2021]
An Open Pilot Trial of Written Exposure Therapy for Patients With Post-Traumatic Stress Disorder in Korea. [2021]
Brief novel therapies for PTSD: Written Exposure Therapy. [2022]
Eye Movement Desensitization and Reprocessing (EMDR) Therapy as a Feasible and Potential Effective Treatment for Adults with Autism Spectrum Disorder (ASD) and a History of Adverse Events. [2021]
Investigating the Feasibility, Acceptability and Efficacy of Using Modified-Written Exposure Therapy in the Aftermath of a Terrorist Attack on Symptoms of Posttraumatic Stress Disorder Among Afghan Adolescent Girls. [2022]
Long-term treatment gains of a brief exposure-based treatment for PTSD. [2022]